SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-335322
Filing Date
2015-10-01
Accepted
2015-10-01 16:16:02
Documents
6
Period of Report
2015-09-29
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d83432d8k.htm 8-K 38532
2 EX-10.38 d83432dex1038.htm EX-10.38 48172
3 EX-10.39 d83432dex1039.htm EX-10.39 15105
4 EX-10.40 d83432dex1040.htm EX-10.40 38622
5 EX-99.1 d83432dex991.htm EX-99.1 18779
6 GRAPHIC g83432snap0002.jpg GRAPHIC 4868
  Complete submission text file 0001193125-15-335322.txt   167355
Mailing Address 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address 3410 CENTRAL EXPRESSWAY SANTA CLARA CA 95051 4086167200
XENOPORT INC (Filer) CIK: 0001130591 (see all company filings)

IRS No.: 943330837 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51329 | Film No.: 151137197
SIC: 2834 Pharmaceutical Preparations